Skip to content
Search

Latest Stories

Whitworth Chemists puts six high-dispensing Blackpool pharmacies up for sale

Whitworth Chemists puts six high-dispensing Blackpool pharmacies up for sale

The family-owned business has decided to sell all 34 pharmacies across the North of England

Whitworth Chemists Limited has instructed the property adviser, Christie & Co, to sell six of its pharmacies in Blackpool, as part of the company’s wider portfolio sale across the North of England.


The pharmacies are located on Kingscote Drive, Charles Street, Whitegate Drive, Bloomfield Road, Waterloo Road, and Common Edge Road.

According to the specialist broker, these are high-dispensing pharmacies, dispensing an average of circa 9,700 items per month.

Some of the accompanying freehold buildings are also up for sale, and interest is invited on a group, subgroup, or individual basis.

Jon Booth, Director – Pharmacy at Christie & Co, who is handling the sale, said: “We are delighted to have been engaged by the family and shareholders of Whitworth Chemists Limited in this exciting project.

“Rarely does a group of this size and quality come to market and be offered for sale on a group, subgroup, or individual pharmacy basis, and we expect significant interest to be generated for the pharmacies,” he added.

John Whitworth first started the pharmacy business in 1967 and, after stepping out of wholesaling, established a new pharmacy chain, Whitworth Chemists Limited in 1999, and since then, the chain remained family-owned.

In total, the family-owned chain has 34 community and health centre pharmacies located across the North of England - nine in Newcastle upon Tyne and Teesside, 10 in Yorkshire and the Humber, five in Greater Manchester and East Lancashire, and 10 in Blackpool and the West Coast.

Across the portfolio, the average dispensing volume is circa 8,500 items per month, with volumes ranging from 3,000 items to 22,000 items.

The decision to sell the business was taken following a strategic review by the family shareholders.

Jay Badenhorst, Managing Director at Whitworth Chemists Limited, and Superintendent Pharmacist, commented, “Whitworth Chemists Limited has built a strong business over the last three decades, delivering a range of quality pharmacy services to a wide patient group across the North of England.

“The business benefits from an amazing, dedicated team delivering first-class pharmacy services daily. However, the time has come for the family shareholders to step back from the business, thereby offering a great opportunity for a new purchaser or purchasers to continue to build on the enviable reputation we have created.”

With its support office in Scunthorpe, North Lincolnshire, the business has centralised services and MHRA-approved warehousing facilities which will also be available for sale, said the property adviser calling it “an opportunity which does not come on the market often.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less